80 related articles for article (PubMed ID: 38371580)
1. Combination of secukinumab and acitretin for generalized pustular psoriasis: A case report and review of literature.
Li J; Wang S; Li XD; Han Y
J Int Med Res; 2024 Apr; 52(4):3000605241247702. PubMed ID: 38661102
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of generalized pustular psoriasis with guselkumab.
Part M
J Dermatolog Treat; 2024 Dec; 35(1):2331807. PubMed ID: 38522861
[No Abstract] [Full Text] [Related]
3. [Translated article] Approach to the Epidemiology, Disease Management, and Current Challenges in the Management of Generalized Pustular Psoriasis Through a Survey Conducted Among Spanish Dermatologists.
Vilarrasa E; Rivera R; Eiris N; Carretero G; de la Cueva P; Carrascosa JM
Actas Dermosifiliogr; 2024 May; 115(5):T449-T457. PubMed ID: 38479699
[TBL] [Abstract][Full Text] [Related]
4. Approach to the Epidemiology, Disease Management, and Current Challenges in the Management of Generalized Pustular Psoriasis Through a Survey Conducted Among Spanish Dermatologists.
Vilarrasa E; Rivera R; Eiris N; Carretero G; de la Cueva P; Carrascosa JM
Actas Dermosifiliogr; 2024 May; 115(5):449-457. PubMed ID: 37925068
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and management of generalized pustular psoriasis (GPP): Experience from the Central and Eastern Europe (CEE) GPP Expert Network.
Wolf P; Ceovic R; Conrad C; Falkensteiner K; Graier T; Kołt-Kamińska M; Marovt M; Mateeva V; Maul JT; Navarini AA; Nicolescu AC; Ratzinger G; Pavlovsky L; Sanzharovskaya M; Szegedi A; Reich A
J Eur Acad Dermatol Venereol; 2024 Jan; ():. PubMed ID: 38279888
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Clinical Presentation, Course, and Burden of Disease in Generalized Pustular Psoriasis [Podcast].
Merola JF; Amin AZ
Clin Cosmet Investig Dermatol; 2024; 17():539-545. PubMed ID: 38482176
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Disease Burden of Patients with Generalized Pustular Psoriasis: A Review of Real-World Evidence.
Bhutani T; Farberg AS
Dermatol Ther (Heidelb); 2024 Feb; 14(2):341-360. PubMed ID: 38363460
[TBL] [Abstract][Full Text] [Related]
8. Generalized pustular psoriasis: A nationwide population-based study using the National Health Data System in France.
Viguier M; Bentayeb M; Azzi J; de Pouvourville G; Gloede T; Langellier B; Massol J; Medina P; Thoma C; Bachelez H
J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):1131-1139. PubMed ID: 38404163
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology, characteristics of disease and unmet needs of patients with generalized pustular psoriasis: a large Italian Delphi consensus.
Prignano F; Atzori L; Bellinato F; Damiani G; Galeone C; Mariani P; Potenza C; Scopinaro A; Piaserico S; Fabbrocini G;
Dermatology; 2024 Mar; ():. PubMed ID: 38493762
[TBL] [Abstract][Full Text] [Related]
10. Spesolimab: A Review of the First IL-36 Blocker Approved for Generalized Pustular Psoriasis.
Pathak GN; Wang E; Dhillon J; Parikh PN; Esseghir R; Rao BK; Feldman SR
Ann Pharmacother; 2024 May; ():10600280241252688. PubMed ID: 38755971
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, incidence, mortality, and healthcare resource use for generalised pustular psoriasis, palmoplantar pustulosis, and plaque psoriasis in England: a population-based cohort study.
Frysz M; Patel S; Li MOY; Griffiths CEM; Warren RB; Ashcroft DM
Br J Dermatol; 2024 May; ():. PubMed ID: 38775029
[TBL] [Abstract][Full Text] [Related]
12. Infliximab in recalcitrant generalized pustular arthropatic psoriasis.
Vieira Serrão V; Martins A; Lopes MJ
Eur J Dermatol; 2008; 18(1):71-3. PubMed ID: 18086593
[TBL] [Abstract][Full Text] [Related]
13. A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks.
Ibba L; Gargiulo L; Pavia G; Narcisi A; Costanzo A; Valenti M
Dermatol Reports; 2024 Mar; 16(1):9722. PubMed ID: 38623366
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 Among Patients with Psoriasis: A Single-Center Retrospective Cross-Sectional Study.
Kaya Ö; Keskinkaya Z; Mermutlu SI; Kılıç SO; Çakır H
Infect Dis Clin Microbiol; 2023 Jun; 5(2):127-135. PubMed ID: 38633013
[TBL] [Abstract][Full Text] [Related]
15. Plaque Psoriasis Exacerbation and COVID-19 Vaccination: Assessing the Characteristics of the Flare and the Exposome Parameters.
Karampinis E; Papadopoulou MM; Chaidaki K; Georgopoulou KE; Magaliou S; Roussaki Schulze AV; Bogdanos DP; Zafiriou E
Vaccines (Basel); 2024 Feb; 12(2):. PubMed ID: 38400161
[TBL] [Abstract][Full Text] [Related]
16. New-onset guttate psoriasis secondary to COVID-19.
Rouai M; Rabhi F; Mansouri N; Jaber K; Dhaoui R
Clin Case Rep; 2021 Jul; 9(7):e04542. PubMed ID: 34336212
[TBL] [Abstract][Full Text] [Related]
17. COVID 19 pneumonia in Down syndrome patients: About 2 cases.
El Kaouini A; El Rhalete A; Aabdi M; Azizi M; Maarad M; Bahouh C; Bkiyer H; Housni B
Ann Med Surg (Lond); 2021 May; 65():102324. PubMed ID: 33907623
[TBL] [Abstract][Full Text] [Related]
18. Involution of classic Kaposi sarcoma lesions under acitretin treatment Kaposi sarcoma treated with acitretin.
Daadaa N; Souissi A; Chaabani M; Chelly I; Ben Salem M; Mokni M
Clin Case Rep; 2020 Dec; 8(12):3340-3343. PubMed ID: 33363930
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-19 and Generalised Pustular Psoriasis: A Lethal Combination.
Narang T; Sharma A; Bhandari A; Handa S; Dogra S
Indian J Dermatol; 2023; 68(6):726. PubMed ID: 38371580
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
